Cargando…
Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3
BACKGROUND: The protease inhibitor, TL-3, demonstrated broad efficacy in vitro against FIV, HIV and SIV (simian immunodeficiency virus), and exhibited very strong protective effects on early neurologic alterations in the CNS of FIV-PPR infected cats. In this study, we analyzed TL-3 efficacy using a...
Autores principales: | de Rozières, Sohela, Swan, Christina H, Sheeter, Dennis A, Clingerman, Karen J, Lin, Ying-Chuan, Huitron-Resendiz, Salvador, Henriksen, Steven, Torbett, Bruce E, Elder, John H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC535546/ https://www.ncbi.nlm.nih.gov/pubmed/15555065 http://dx.doi.org/10.1186/1742-4690-1-38 |
Ejemplares similares
-
Crystal structure of an FIV/HIV chimeric protease complexed with the broad-based inhibitor, TL-3
por: Heaslet, Holly, et al.
Publicado: (2007) -
Evaluation of a Point-of-Care Feline Immunodeficiency Virus (FIV) Test Kit (RapidSTATUS™ FIV) to Determine the FIV Status of FIV-Vaccinated and FIV-Unvaccinated Pet Cats in Australia
por: Cheang, Ashley, et al.
Publicado: (2022) -
Enrichment Preferences of FIV-Infected and Uninfected Laboratory-Housed Cats
por: Kennedy, Claudia J., et al.
Publicado: (2018) -
Acute phase response to Mycoplasma haemofelis and ‘Candidatus Mycoplasma haemominutum’ infection in FIV-infected and non-FIV-infected cats
por: Korman, R.M., et al.
Publicado: (2012) -
Applications of the FIV Model to Study HIV Pathogenesis
por: Miller, Craig, et al.
Publicado: (2018)